What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Gene
- Cancer
Kevin K. Brown mainly focuses on Idiopathic pulmonary fibrosis, Pulmonary fibrosis, Internal medicine, Pathology and Surgery.
Kevin K. Brown studies Usual interstitial pneumonia, a branch of Idiopathic pulmonary fibrosis.
Kevin K. Brown has researched Pulmonary fibrosis in several fields, including Survival rate, Respiratory disease, PEDF and Epidemiology.
His Internal medicine research is multidisciplinary, incorporating perspectives in Gastroenterology and Cardiology.
His Pathology study combines topics from a wide range of disciplines, such as Endothelial stem cell, Hypersensitivity pneumonitis, Interstitial pneumonia and Interstitial lung disease.
His Surgery research is multidisciplinary, relying on both Placebo, FEV1/FVC ratio and Urology.
His most cited work include:
- An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-Based Guidelines for Diagnosis and Management (4402 citations)
- American thoracic society/European respiratory society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias (3012 citations)
- Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis (2009 citations)
What are the main themes of his work throughout his whole career to date?
The scientist’s investigation covers issues in Idiopathic pulmonary fibrosis, Internal medicine, Pathology, Interstitial lung disease and Lung.
The various areas that Kevin K. Brown examines in his Idiopathic pulmonary fibrosis study include Pulmonary fibrosis, Physical therapy and Intensive care medicine.
His Pulmonary fibrosis study combines topics in areas such as Survival rate, Respiratory disease and Intensive care.
His Internal medicine research incorporates themes from Gastroenterology, Surgery and Cardiology.
His research integrates issues of Idiopathic interstitial pneumonia, Interstitial pneumonia and Pneumonia in his study of Pathology.
His Interstitial lung disease research incorporates elements of Arthritis, Scleroderma, Connective tissue disease, Hypersensitivity pneumonitis and Rheumatoid arthritis.
He most often published in these fields:
- Idiopathic pulmonary fibrosis (37.72%)
- Internal medicine (33.93%)
- Pathology (28.79%)
What were the highlights of his more recent work (between 2018-2021)?
- Internal medicine (33.93%)
- Idiopathic pulmonary fibrosis (37.72%)
- Lung (21.87%)
In recent papers he was focusing on the following fields of study:
Kevin K. Brown mostly deals with Internal medicine, Idiopathic pulmonary fibrosis, Lung, Interstitial lung disease and Nintedanib.
His Internal medicine research is multidisciplinary, incorporating perspectives in Gastroenterology, Placebo, Oncology and Cardiology.
His biological study spans a wide range of topics, including Pulmonary fibrosis, Vital capacity and DLCO.
His Pulmonary fibrosis study is focused on Pathology in general.
His work carried out in the field of Vital capacity brings together such families of science as Clinical trial and Intensive care medicine.
The Interstitial lung disease study combines topics in areas such as Scleroderma, Connective tissue disease, Hypersensitivity pneumonitis and Rheumatology.
Between 2018 and 2021, his most popular works were:
- Nintedanib in Progressive Fibrosing Interstitial Lung Diseases (300 citations)
- Nintedanib in patients with progressive fibrosing interstitial lung diseases—subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial (55 citations)
- Interstitial lung disease associated with systemic sclerosis (SSc-ILD). (47 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Gene
- Cancer
Kevin K. Brown spends much of his time researching Idiopathic pulmonary fibrosis, Internal medicine, Interstitial lung disease, FEV1/FVC ratio and Lung.
His Idiopathic pulmonary fibrosis study combines topics in areas such as Vital capacity, DLCO, Gastroenterology, Gene and Lung biopsy.
Kevin K. Brown has included themes like Immune dysregulation and Review article, Pathology in his DLCO study.
Internal medicine is often connected to Placebo in his work.
His work on Usual interstitial pneumonia as part of general Interstitial lung disease study is frequently linked to Multidisciplinary approach, therefore connecting diverse disciplines of science.
His Usual interstitial pneumonia study incorporates themes from Autoantibody and Rheumatoid arthritis.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
